What's in Jordan Collaborating Cardiology Group's pipeline?

Jordan Collaborating Cardiology Group has 2 drugs in our index: 1 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 1 in Phase 1.

Which companies overlap with Jordan Collaborating Cardiology Group's portfolio?

Top competitors by shared drug class: Ahn-Gook Pharmaceuticals Co.,Ltd, AstraZeneca, AstraZeneca (originally Astra AB), Baxter, Charles Mel Wilcox, MD.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/jordan-collaborating-cardiology-group.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Jordan Collaborating Cardiology Group — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Jordan Collaborating Cardiology Group pipeline: 1 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 0 Phase 2 1 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Lansoprazole Pill	Lansoprazole Pill	marketed	Proton pump inhibitor (PPI)	H+/K+-ATPase (proton pump)	Gastroenterology

Therapeutic area mix

Gastroenterology · 1
Other · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Ahn-Gook Pharmaceuticals Co.,Ltd · 1 shared drug class
AstraZeneca · 1 shared drug class
AstraZeneca (originally Astra AB) · 1 shared drug class
Baxter · 1 shared drug class
Charles Mel Wilcox, MD · 1 shared drug class
China-Japan Friendship Hospital · 1 shared drug class
Chinese University of Hong Kong · 1 shared drug class
Abbott · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Jordan Collaborating Cardiology Group:

Cite this brief

Drug Landscape (2026). Jordan Collaborating Cardiology Group — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/jordan-collaborating-cardiology-group. Accessed 2026-05-17.